Emflaza

Deflazacort

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。
more
パッケージ あたり 錠剤 価格 節約 ご注文
180 tablet
¥ 106.54
¥ 19177.42¥ 106.54
¥ 33905.45
120 tablet
¥ 122.92
¥ 14750.16¥ 122.92
¥ 20638.42
90 tablet
¥ 147.49
¥ 13274.41¥ 147.49
¥ 13267.03
60 tablet
¥ 184.35
¥ 11060.78¥ 184.35
¥ 6633.51
30 tablet
¥ 294.90
¥ 8847.15¥ 294.90
パッケージ あたり 錠剤 価格 節約 ご注文
120 tablet
無料航空便配送 Hot
¥ 676.33
¥ 81159.09¥ 676.33
¥ 14728.02
90 tablet
無料航空便配送 Hot
¥ 713.20
¥ 64187.92¥ 713.20
¥ 7727.42
60 tablet
無料航空便配送 Hot
¥ 737.75
¥ 44265.24¥ 737.75
¥ 3678.32
36 tablet
無料航空便配送 Hot
¥ 778.67
¥ 28031.95¥ 778.67
¥ 734.19
24 tablet
¥ 799.06
¥ 19177.42¥ 799.06
パッケージ あたり 錠剤 価格 節約 ご注文
90 tablet
無料航空便配送 Hot
¥ 819.78
¥ 73780.32¥ 819.78
¥ 14737.25
60 tablet
無料航空便配送 Hot
¥ 885.33
¥ 53119.77¥ 885.33
¥ 5891.95
36 tablet
無料航空便配送 Hot
¥ 942.64
¥ 33934.96¥ 942.64
¥ 1472.06
24 tablet
無料航空便配送 Hot
¥ 983.53
¥ 23604.69¥ 983.53
Emflaza

ブランド

製造元

  • Lupin

病衣

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.